Safety, Efficacy, PD of FE203799 in Short Bowel Syndrome on Parenteral Support

NCT03415594 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Short Bowel Syndrome

Interventions

DRUG: FE203799 GLP-2 analogue
DRUG: FE203799 Placebo GLP-2 analogue
DRUG: FE203799 GLP-2 analogue

Sponsor

GlyPharma Therapeutics

Collaborators

[object Object]